Orchid receives US FDA approval for Cefuroxime

New Delhi, Feb 20 (UNI) Orchid Chemicals&Pharmaceuticals Ltd today said it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Cefuroxime Axetil Tablets.

The product is available in three dosage strengths, 125 mg, 250 mg and 500 mg, said a statement.

This is the 25th ANDA approval that the Company has received since it started its US Generics journey in 2005.

UNI PBB RL SSC1157